The De Vega tricuspid annuloplasty. Perioperative mortality and long term follow-up.
One hundred and fifty-three patients undergoing De Vega tricuspid annuloplasty, with or without other associated cardiac procedures between January, 1979, and June, 1987, were evaluated. There were 136 hospital survivors. The follow-up was 98.1% complete for a mean of 3.7 years/patient. Operative mortality was 11.1%; preoperative NYHA class and length of CPB were significant risk factors of perioperative mortality. The actuarial survival of operative survivors at 9 years was 73.5 +/- 11.8%. There were 7 late cardiac deaths among a total of 12 late deaths. Eleven patients required reoperation (2.1 +/- 0.6% patient-year). In seven patients it was necessary for recurrence of tricuspid regurgitation; six of these had also a mitral prosthesis malfunction or a periprosthetic leak. Residual tricuspid regurgitation was judged as mild, moderate or severe in 29.9%, 11.9% and 4.3% of the patients respectively. De Vega tricuspid annuloplasty is the method of choice for mild and moderate tricuspid insufficiency; in selected cases, with a more severe degree of regurgitation, better results could be achieved with a different surgical approach.
De Paulis
R
R
Cattedra di Cardiochirurgia, Università degli Studi di Torino, Turin, Italy.
Bobbio
M
M
Ottino
G
G
Donegani
E
E
Di Rosa
E
E
Casabona
R
R
Girotto
M
M
Morea
M
M
D000293:Adolescent; D000328:Adult; D000368:Aged; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007432:Intraoperative Period / Q000401:mortality; D008297:Male; D008722:Methods; D008875:Middle Aged; D011183:Postoperative Complications / Q000401:mortality*; D012086:Reoperation; D012307:Risk Factors; D015996:Survival Rate; D014262:Tricuspid Valve Insufficiency / Q000601:surgery*